መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › አላባማ › Birmingham
በBirmingham፣ AL ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 22 ጥናቶች በBirmingham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Central Alabama Research ( Site 0108), Birmingham
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Alabama Oncology, Birmingham
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Alabama Oncology, St Vincent's Birmingham, Birmingham
- Alabama Oncology, Brookwood, Birmingham
- Alabama Oncology, Princeton, Birmingham
- እና 5 ተጨማሪ
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Alabama at Birmingham, Birmingham
Pan-tumor MRD Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Alabama Oncology, Birmingham
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Alabama at Birmingham, Birmingham
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Local Institution - 0347, Birmingham
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology, Birmingham
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UAB Medicine - UAB Hospital, Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Alabama at Birmingham, Birmingham
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The University of Alabama, Birmingham
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- O'Neal Comprehensive Cancer Center at UAB, Birmingham
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Uni of Alabama at Birmingham, Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Alabama at Birmingham, Birmingham
- University of Alabama at Birmingham, IDS Pharmacy, Birmingham
- University of Alabama at Birmingham, Birmingham
- እና 1 ተጨማሪ
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Central Alabama Research, Birmingham
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Alabama at Birmingham, Birmingham
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
ተሳታዮችን በመፈለግ ላይ
- University of Alabama at Birmingham, Birmingham
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The University of Alabama at Birmingham Hospital, Birmingham
GEMINI-NSCLC: NSCLC Biomarker Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Alabama Oncology, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Birmingham
በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች
- Houston, TX145 ጥናቶች
- New York City, NY121 ጥናቶች
- Arlington, VA104 ጥናቶች
- Nashville, TN97 ጥናቶች
- Boston, MA90 ጥናቶች
- Los Angeles, CA87 ጥናቶች
- St. Louis, MO73 ጥናቶች
- Chicago, IL61 ጥናቶች
- Baltimore, MD60 ጥናቶች
- San Antonio, TX59 ጥናቶች
- Columbus, OH57 ጥናቶች
- Washington, DC55 ጥናቶች
በBirmingham ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)31 ጥናቶች
- የጡንቻ ካንሰር24 ጥናቶች
- የእንቁላል ካንሰር23 ጥናቶች
- ከባድ ሰውነት23 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ21 ጥናቶች
- Multiple Myeloma18 ጥናቶች
- ሲ.ኦ.ፒ.ዲ17 ጥናቶች
- የልብና የደም ዝውውር ሕመም17 ጥናቶች
- የ2 ዓይነት ስኳረት16 ጥናቶች
- የኤንዶሜትሪየም ካንሰር16 ጥናቶች
- ከመጠን በላይ ክብደት16 ጥናቶች
- ሲስቲክ ፋይብሮሲስ16 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።